4//SEC Filing
Brewis Neil 4
Accession 0001209191-22-022298
CIK 0001566373other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:02 PM ET
Size
5.9 KB
Accession
0001209191-22-022298
Insider Transaction Report
Form 4
Brewis Neil
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-31+132,469→ 132,469 totalExercise: $3.55Exp: 2032-03-31→ Common Stock (132,469 underlying)
Footnotes (2)
- [F1]These options were granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, March 31, 2022, and thereafter in 36 equal monthly installments such that the stock option shall be fully-vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001831247
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:02 PM ET
- Size
- 5.9 KB